Number of Shares
64,285.00
Current Holdings Value*
$5.69 Mil
% of Portfolio
1.42%
Total Estimate Gain
$3.13 Mil
% of Total Estimate Gain
43.31%

NYLI VP Small Cap Growth Portfolio's Blueprint Medicines Corp Holding Summary

As of 2025-03-31, NYLI VP Small Cap Growth Portfolio held 64,285.00 shares of Blueprint Medicines Corp(BPMC), totaling $5.69 Mil. This investment constitutes 1.42% of their stock portfolio, and NYLI VP Small Cap Growth Portfolio now holds 0.1% of the outstanding Blueprint Medicines Corp(BPMC) stock.

The initial trade took place in 2019Q3. And since then NYLI VP Small Cap Growth Portfolio has made 9 purchases of BPMC, at an average price of $78.64, for a total of 91,932.00 shares. In addition, there have been 10 sales at an average price of $73.75 for 27,647.00 shares. Based on historical transaction data and BPMC's current price of $129.46, NYLI VP Small Cap Growth Portfolio's estimated gain on his BPMC holdings is $3.13 Mil, reflecting a 43.31% gain to date.

NYLI VP Small Cap Growth Portfolio BPMC ($129.46) Holding Chart

NYLI VP Small Cap Growth Portfolio BPMC ($129.46) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1